KRAS G12D Mutation
Oncology·MeSH: Pancreatic Neoplasms
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| mrtx1133 | Mirati Therapeutics, Inc. (MRTX) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| ARV-806 | ARVINAS, INC. (ARVN) |
Compare drugs
Frequently asked questions
How many drugs are in development for KRAS G12D Mutation?
BioSniper tracks 2 drugs in development for KRAS G12D Mutation across 2 companies.
How many clinical trials target KRAS G12D Mutation?
There are 1 clinical trial targeting KRAS G12D Mutation tracked by BioSniper.
Deep-dive into KRAS G12D Mutation
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis